Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD)

Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD).

About 5% of reproductive age women have this more severe form of premenstrual syndrome.

Yaz contains the same ingredients as Yasmin, but with less estrogen per pill. Also, Yaz has four days of placebo a pack...Yasmin has seven.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote